NASDAQ · FTREHealthcareMedical Labs

Fortrea Holdings financials

$19.74−1.60%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
Revenue$2.72B$2.70B$2.84B
Gross profit$503.8M$534.2M$590.6M
Gross margin18.5%19.8%20.8%
Operating income-$872.6M-$161.9M$32.0M
Net income-$986.2M-$328.5M-$25.2M
Net margin−36.2%−12.2%−0.9%
Diluted EPS$-10.81$-3.67$-0.29
EBITDA$47.4M-$24.9M$151.2M
Operating cash flow$113.5M$262.8M$168.4M
Free cash flow$88.3M$237.3M$128.1M
Diluted shares91.2M89.5M88.8M

Balance sheet

Period endDec 31Dec 31Dec 31
Cash & equivalents$174.6M$118.5M$108.6M
Short-term investments$0.00$0.00$0.00
Total debt$1.05B$1.12B$1.59B
Total assets$2.72B$3.58B$4.33B
Total liabilities$2.15B$2.22B$2.62B
Shareholders' equity$563.5M$1.36B$1.71B

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology